A
$ Value
$13K
Shares
833
Price
$15
Filed
Jul 1
Insider
Name
Leonard Frank X
Title
EVP, Pres., Novocure Oncology
CIK
0001822879
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
348,711
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2025 through June 30, 2025. This transaction is also exempt under Rule 16b-3(c). | In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025.